3295.4000 39.40 (1.21%)
NSE Aug 13, 2025 15:53 PM
Volume: 98,394
 

3295.40
1.21%
Emkay
We met DLPL’s MD Dr. Om Manchanda to gauge competitive intensity and its strategy to boost volumes. Meeting KTAs are: 1) DLPL is increasingly witnessing the ‘bundling’ phenomenon as doctors are recommending multiple tests to ascertain accurate prognosis.
Dr. Lal Pathlabs Ltd. is trading above all available SMAs
More from Dr. Lal Pathlabs Ltd.
Recommended